banner-home

It’s time to shift the needle to prevent diabetic retinopathy

graphic of a purple and blue eye

The time has come to take meaningful action to stop the advance of a debilitating vision disorder known as diabetic retinopathy (DR), which affects some 93 million adults worldwide. To inform actions, a unique international coalition of ageing, diabetes and vision advocates undertook the DR Barometer Study – in-depth interviews in eight countries and then a global survey of close to 7,000 adults with diabetes and their health care providers.

This study has generated new and vital insights on how diabetes-related vision loss affects individuals and their families, and what people living with diabetes, physicians, patient advocates, and policy makers around the world can do locally to prevent, diagnose, and treat this life-altering condition.

Introducing the DR Barometer

The International Federation on Ageing (IFA), the International Agency for the Prevention of Blindness (IAPB), the International Diabetes Federation (IDF), and Vision Academy – supported by Bayer– have come together to shine a spotlight on the prevention, assessment and treatment of the potentially devastating consequences of DR.


The DR Barometer is a ground-breaking study of close to 7,000 adults with diabetes and health care professionals from across 41 countries. It provides vital evidence and insights into how vision impairment and loss resulting from diabetes impacted the lives of individuals and those around them.

41
countries

globe

7000
adults

A closer look at 
diabetic retinopathy

DR is a common complication of diabetes caused by high blood sugar levels, which over time can cause damage to the back of the eye. DR may remain undetected initially, but as it progresses the disease can lead to blindness.

As it progresses, DR can result in patches of vision loss, blurry vision, cloudy vision, or colors that look washed out or faded. If undiagnosed and untreated, DR can lead to blindness, which brings with it a range of consequences affecting not only the person’s physical and mental wellbeing but roles and responsibilities within the family, and their ability to contribute to community.

Diabetes remains one of the world’s most pressing public health concerns, affecting one in every eleven people – a total of 415 million adults.

All people with type 1 and type 2 diabetes are at risk of developing DR.

Communities of Practice

The DR Barometer Program’s three CoPs, Patient Education and Empowerment, Coordinated Care and Guidelines and Protocols encapsulate the priority areas identified through the ground-breaking DR Barometer study and provide an evidence-based foundation with which to drive meaningful change in the screening, treatment, and prognosis of diabetic retinopathy for adults living with diabetes.

 

banner-join-community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes. 

 

The Global Evidence

The time has come to take meaningful action to stop the advance of a debilitating vision disorder known as diabetic retinopathy (DR), which affects some 93 million adults worldwide. To inform actions, a unique international coalition of ageing, diabetes and vision advocates undertook the DR Barometer Study – in-depth interviews in eight countries and then a global survey of close to 7,000 adults with diabetes and their health care providers.

Learn More

global-findings-report